asenapine
Asenapine has been approved by the FDA for the acute treatment of adults with schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder with or without psychotic features in adults.. Reference standards of Asenapine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => Asenapine N-β-D-Glucuronide Trifluoroacetic Acid Salt (Mixture of Diastereomers)
[catalogue_number] => PA 01 78550
[category_ids] => ,70,71,78,82,89,95,
[chemical_name] =>
[weight] => 575.92
[form] => C23H25CF3NO9
[cas] => NA
[pslug] => asenapine-n-beta-d-glucuronide-trifluoroacetic-acid-salt-mixture-of-diastereomers-pa0178550
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Asenapine N-β-D-Glucuronide Trifluoroacetic Acid Salt (Mixture of Diastereomers)
Catalogue No.:PA 01 78550
Molecular Formula : C23H25CF3NO9
Molecular Weight : 575.92